US Liquid Biopsy Market

In 2017, the US Liquid Biopsy market was estimated at $400 million, more than double the value of the previous year. The big centralized data business model has established itself as a winner in terms of growth and robustness with Exact Sciences Corporation more than doubling its revenue in 2017 and capturing close to 45% of the market.